Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDHP0151Y/10
CompoundAxomadol
Trials sponsorGrünenthal GmbH
Trial phase1
Brief titleA Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated
IndicationPain, Acute Pain, Chronic Pain
UTN
CTG IDNCT03765658
CTIS ID (former EudraCT)
Trial statusCompleted
FPIJanuary 20, 2006
LPOMarch 2, 2006
CountriesCanada
GenderAll
Age18 and 55 years
ResultsNo
Pubmed
Documents